|
|
||||||||
LETTERS TO THE EDITOR |
Instituto Gulbenkian de Ciência, Oeiras, Portugal
The injection of anti-CD25 mAb to deplete CD25+ regulatory T cells (TR) in mice has been common practice to infer the function of TR. In a recent report, Kohm et al. (1) claimed that injection of anti-CD25 mAb in mice results in the functional inactivation, not depletion, of CD4+CD25+ TR. This conclusion was based on the analysis of mice that received the rat-IgM 7D4 mAb or the rat IgG PC61. CD25 and FOXP3 expression was determined by FACS analysis after 7D4 treatment but solely by RT-PCR after PC61 administration (1). Using FACS analysis in both cases, we enumerated CD4+CD25+ and CD4+FOXP3+ cells in blood, spleen, and lymph nodes isolated from mice treated with either 7D4 or PC61 (Fig. 1). Similarly to Kohm et al., we found that despite the disappearance of surface CD25 expression, FOXP3+ cell frequency is not affected by 7D4 administration, irrespective of the tissue analyzed and independently of the dose used (up to 3 mg/mouse). In contrast, injection of as little as 500 µg/mouse of PC61 resulted in both the disappearance of CD25+ cells and the loss of CD4+FOXP3+ cells. In PBL, the frequency of CD4 cells expressing FOXP3 is reduced from an average of 8 to 3%, indicating that >65% of the total FOXP3+ cells are depleted. The disappearing cells are the bulk of the FOXP3+CD25+ TR, while the pre-existing FOXP3+CD25 subset appeared maintained. In spleen,
45% of the FOXP3+ cells were depleted. TR originally CD25+ that lost CD25 expression and pre-existing CD25 TR appeared to contribute equally to the remaining FOXP3+ cell pool. In lymph nodes, depletion was less marked and corresponded to the disappearance of 33% of the FOXP3+CD25+. Increasing the amount of PC61 injected (up to 3 mg/mouse) did not dramatically increase the depletion efficiency (data not shown). We conclude that injection of the rat-IgG PC61 mAb, which has been the most frequently used to interfere with TR function in vivo, does result in depletion of a large fraction of TR.
|
References
This article has been cited by other articles:
![]() |
S. Piconese, B. Valzasina, and M. P. Colombo OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection J. Exp. Med., April 14, 2008; 205(4): 825 - 839. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Guilliams, G. Oldenhove, W. Noel, M. Herin, L. Brys, P. Loi, V. Flamand, M. Moser, P. De Baetselier, and A. Beschin African Trypanosomiasis: Naturally Occurring Regulatory T Cells Favor Trypanotolerance by Limiting Pathology Associated with Sustained Type 1 Inflammation J. Immunol., September 1, 2007; 179(5): 2748 - 2757. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Couper, D. G. Blount, J. B. de Souza, I. Suffia, Y. Belkaid, and E. M. Riley Incomplete Depletion and Rapid Regeneration of Foxp3+ Regulatory T Cells Following Anti-CD25 Treatment in Malaria-Infected Mice J. Immunol., April 1, 2007; 178(7): 4136 - 4146. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dai, B. Liu, S. M. Ngoi, S. Sun, A. T. Vella, and Z. Li TLR4 Hyperresponsiveness via Cell Surface Expression of Heat Shock Protein gp96 Potentiates Suppressive Function of Regulatory T Cells J. Immunol., March 1, 2007; 178(5): 3219 - 3225. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Kohm and S. D. Miller Response to Comment on "Cutting Edge: Anti-CD25 Monoclonal Antibody Injection Results in the Functional Inactivation, Not Depletion, of CD4+CD25+ T Regulatory Cells" J. Immunol., August 15, 2006; 177(4): 2037 - 2038. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |